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Objectives: To evaluate the prevalence ofabdominal ortic aneurysms (AAA) in a general population and to compare the 
results with those of similar studies in other countries. 
Design: Ultrasound screening study and collection of clinical and biochemical data. 
Setting: An urban Health Service District in Genoa, Italy. 
Materials: A general population, aged 65-75 years, invited by personal letter between 1991-1994. 
Results: 1601 subjects (741 males and 860 females) out of 2734 invited (58.5%) were evaluated. According to the 
ultrasound findings, 27 patients (I.7%) had an aortic dilatation of 26-29 ram; an AAA of 30-39 mm was found in 37 
(2.3%) and an AAA > 40 mm in 33 (2.1%). The overall prevalence for AAA was 4.4% (8.8% in males and 0.6% in females 
respectively). The prevalence of smoking, alcohol consumption, coronary heart disease, chronic obstructive pulmonary 
disease and arterial disease were significantly higher in patients with AAA (p < 0.01). 
Conclusions: Ultrasound screening for AAA is a reliable and useful method and should be focused on men, regardless of
concurrent disease. 
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Introduction 
A screening program in a general population in 
northern Italy is reported with the aim of evaluating 
the prevalence of abdominal aortic aneurysms (AAA) 
and associated cardiovascular risk factors and com- 
paring our data with those of other authors in 
different countries. 
Materials and Methods 
A personal etter of invitation was sent to all the 
subjects of one Health Service District in Genoa aged 
65-75 years under the care of participating GPs. 
Similar leaflets were posted in the GPs' offices and in 
the out-patient clinics of the same area. Those who 
accepted were first interviewed by their GP according 
to a survey that covered medical histor~ current 
therap)~ smoking and alcohol habits, basic clinical 
data (blood pressure, heart rate, body weight and 
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height) and then given an appointment for the 
additional tests. 
Arteriopathy was defined as claudication (PAOD), 
previous transient ischaemic attacks or stroke (TIA); 
coronary heart disease (CHD) as angina or previous 
myocardial infarction; dyslipidaemia as total choles- 
terol >240 mg/dl  or triglycerides >250 mg/dl; 
chronic obstructive pulmonary disease (COPD) as 
asthma, emphysema or chronic bronchitis; hyper- 
tension as diastolic pressure >100 mmHg and/or 
medical treatment. 
Abdominal ultrasound scans were performed at a 
local outpatient clinic by two radiologists from our 
University (C.P. and R.P.), using a B-mode linear 
ultrasonography machine (Toshiba SAL 30). The max- 
imal anteroposterior (AP) and transverse (LL) diame- 
ters of the suprarenal (S) and infrarenal (I) aorta were 
measured in each patient. All measurements were 
performed by the two radiologists independently and 
then expressed as a mean. 
AAA was defined as any aortic dilatation > 29 mm 
in either the AP or the LL plane. All cases with an 
aortic diameter > 25 mm were registered. All patients 
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Table 1. Results of the ultrasound screening. Values are mean and (S.D.) 
Group No. patients % 
Diameters (mm) 
Suprarenal Infrarenal 
Anteroposterior Transverse Anteroposterior Transverse 
A 1504 93.94 
B 27 1.68 
C 37 2.31 
D 33 2.06 
16.6 (2.7) 18.5 (2.9) 14.7 (2.6) 16.5 (2.8) 
20.8 (3.7) 22.4 (3.7) 22.9 (3.8) 26.4 (2.5) 
21.8 (4.5) 23.5 (4.5) 28.6 (4.6) 31.1 (3.7) 
23.0 (4.1) 24.4 (4.4) 46.5 (8.8) 49.2 (9.9) 
with an enlarged aorta (> 25 mm) were subsequently 
evaluated at the University Dept. of Radiology by the 
same radiologists under the supervision of a senior 
(G.C.) using a more advanced ultrasound scanner 
(Esaote Biomedica AU 450). Those with confirmed 
aortic dilatation > 25 mm were then seen by the 
clinical study coordinator (G.S.). Patients with AAA 
< 40 mm were followed up at 6 month intervals with 
further scans. Patients with AAA a 40 ram, those with 
an expansion rate _ 5 mm in 6 months and those with 
symptoms were evaluated for surgical repair. 
Statistical analysis 
Data are summarised as mean and standard eviation 
(S.D.) for continuous, and as frequency tables for 
qualitative variables. 
The analysis of the risk factors took into account 
only patients with AAA a30 mm vs. those with 
normal aortic size, excluding the grey area ranging 
from 26-29 mm. 
StatiStical analysis was performed using the Stu- 
dent's t-test and the chi-square test with significance 
declared at the 5% level. 
Results 
Between March 1991 and March 1994, 2734 patients 
from 26 GPs were invited to enter the study; 1601 
(58.5%) with mean age 69 (S.D. = 3) years, accepted 
(741 males and 860 females). 
The patients were classified into four groups accord- 
ing to abdominal ultrasound results: (A) normal aortic 
size, (B) aortic dilatation 26-29 mm, (C) AAA 30-39 
mm, (D) AAA a 40 mm. Results are shown in Table 1. 
The mean age was 69.3 (S.D. = 3.0) in group A, 69.7 
(S.D. --2.7) in B, 69.2 (S.D. = 3.1) in C and 70.1 (S.D. 
= 2.7) in D. Taking into account groups B + C + D (97 
patients) and groups C + D (70 patients), the overall 
prevalence of AAA was 6.1% and 4.4%, respectively. 
For AAA >29 mm the prevalence was 8.8% (65 
patients) for the males and 0.6% (five patients) for the 
females. 
In the group with AAA a 40 mm (32 males and one 
female) 24 underwent elective surgical repair (one 
death occurred in the postoperative p riod from acute 
respiratory distress syndrome), four refused surgery 
for personal reasons and five were considered unfit for 
surgery. Among these latter, one died from myocardial 
infarction (70 mm), one from stroke (42 mm), two 
ruptured (110 ram, 56 ram) at 1, 8, 22 and 24 months of 
follow-up, respectively. 
In the group with AAA of 30-39 mm (33 males and 
four females ) six patients with AAA increasing to 
more than 40 mm (18 months) underwent successful 
elective surgery; two refused follow-up and two died 
from concurrent neoplasms at 3 and 9 months. The 
remaining 27 patients are currently undergoing reg- 
ular ultrasound follow-up. Among the 27 patients (22 
males and five females) with an ectastic aorta (26-29 
ram), two refused the follow-up and one died from 
stroke at 28 months; the remaining 24 are undergoing 
regular follow-up. 
Smoking, alcohol consumption, coronary heart dis- 
ease, chronic obstructive pulmonary disease and 
arterial diseases were found to be statistically more 
prevalent (p < 0.001) in patients with AAA compared 
to those without AAA. The mean blood pressure was 
144/83 mmHg in the patients with normal aortic size 
and 150/83 mmHg in patients with AAA. An electro- 
cardiogram was performed in 850 patients (414 males 
and 436 females), classified according to the main 
groups of the Minnesota code, 1 and confirmed the 
clinical data on cardiac disease showing a significant 
difference between 778 normal subjects and 53 
patients in group C + D (p < 0.001) (Table 2). 
Discussion 
The prevalence of AAA has shown an increasing trend 
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Table 2. Associated risk factors in 1504 subjects with normal aortic 
size and 70 with AAA > 29 mm 
Normal (%) AAA(%) x2 d.f. p 
Smokers 
No 59.7 
Ex 25.8 
Yes 14.5 
Alcohol 
No 58.6 
Yes 41.4 
Arteriopathy 
TIA 3.1 
PAOD 9.8 
No 87.1 
CHD 
No 83.2 
Yes 16.8 
ECG 
Normal 58.2 
Abnormal 41.8 
Dyslipidoaemia 
No 66.9 
Yes 33.1 
Diabetes 
No 85.9 
Yes 14.1 
COPD 
No 91.6 
Yes 8.4 
Hypertension 
No 55.8 
Yes 44.2 
11.3 
49.5 
39.2 
66.57 2 <0.001 
35.1 
64.9 14.31 1 <0.001 
2.1 
23.7 
74.2 
15.42 2 <0.001 
62.9 
37.1 18.94 1 <0.001 
28.3 
71.7 18.06 1 <0.001 
64.9 
35.1 0.20 1 0.651 
85.6 
14.1 0.002 1 0.964 
68.0 
32.0 41.72 1 <0.001 
45.7 
54.3 2.74 1 0.098 
AAA = abdominal aortic aneurysm; TIA = transient ischaemic attacks; 
PAOD = arterio pathy; CHD = coronary heart disease; COPD = chromic 
obstructive pulmonary disease. 
over the last few decades (4.7/100 00 subjects in 1951, 
31.9/100 00 in 1980) and this situation does not seem 
related to more reliable diagnostic methods alone. 2
The natural history of AAA shows a trend towards 
expansion and rupture according to the initial size. 3-6 
Unfortunatel)~ the treatment of associated risk factors 
does not significantly modify this trend, even if the 
use of fl-blockers may be helpful in controlling the 
growth of aortic aneurysms 7 and stopping smoking 
may reduce the risk of death. 8 
The efficacy of screening programme for asympto- 
matic AAA has already been emphasised by many 
9 ~12 authors from different countries. - Our results con- 
firm the findings. An attendance of 58.5% is in the 
range of the other studies 13-21 on healthy populations 
(46%-79%), but was probably affected by the unex- 
pectedly low acceptance rate of local GPs. This may 
reflect he behaviour of some practitioners who do not 
tolerate 'interference' with their practices or who 
simply consider screening programmes as academic 
studies rather than reliable means for prevention. 
Although the criteria both for patient selection and 
the definition of AAA 13-21 differ, our prevalence data 
are in keeping with those of the literature. Our overall 
prevalence for AAA > 29 mm (4.4%) is remarkably 
similar to that of Scott et al. 2o who screened over 8000 
subjects of both sexes aged 65-80. Moreover, the 
prevalence for males (8.8%) in our series fits with 
similar screening programmes (range 5.4%-10.7%) 
and underlines the very low prevalence in females 
(0.6%). 
Risk factors have not been reported in all the series 
on healthy population. There is general agreement on 
smoking 8,14-16,18,21 but few studies have shown a 
statistical significance for CHD, 14'16"21 COPD, 14'21 
arterial disease 14"21 and alcohol consumption. 14 Only 
Krohn et alJ 6 have reported hypertension as a main 
risk factor, but the contrary has been asserted by 
others 14,20,21 and none have indicated dyslipidae- 
mia. 14'16 These two last findings are consistent with 
the emerging thoughtithat herosclerotic and aneur- 
ysmal diseases mu,~t~be, distinguished astwo different 
entities, 22 and tha(hypertension plays a major role in 
the expansion of the AAA rather than in its patho- 
genesis. 23,24 Our results confirm a statistical sig- 
nificance for the risk factors above. 
The final issues concern which subjects to screen 
and when to operate. Regarding the former, we have 
based our selection on reports in the literature which 
indicate that the population aged 65-75 is that most 
likely to benefit o the greatest extent, from screening 
in terms of life expectancy. The second question is 
more open to debate. Given that results of ongoing 
U.K. and Canadian trials on the management of small 
AAA are not yet available, we opted to operate on 
AAA _ 40 mm. 25'26 
In conclusion, the results of our screening study 
show a prevalence of asymptomatic AAA in a general 
population in our area, which is comparable to that of 
similar series carried out in other European 
countries. 
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